Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Swain

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
Brain, Behavior, and Immunity|June 28, 2020
Brain TNF drives post-inflammation depression-like behavior and persistent pain in experimental arthritisFernando Lopes, Fernando A Vicentini, Nina L Cluny, et al.
CMAJ Open|June 10, 2017
Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort studyKeith C K Lau, Abdel Aziz Shaheen, Alexander A Aspinall, et al.
Canadian Liver Journal|December 25, 2023
Real-world tertiary referral centre experience stopping nucleos(t)ide analogue therapy in patients with chronic hepatitis BHassan Azhari, Alexandra D Frolkis, Abdel Aziz Shaheen, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2020
Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North AmericaGolasa Samadi Kochaksaraei, Eliana Castillo, Matthew D Sadler, et al.
Journal of Hepatology|March 25, 2024
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort studyChristina G Plagiannakos, Gideon M Hirschfield, Ellina Lytvyak, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label StudyJordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.
Brain, Behavior, and Immunity|June 28, 2020
Brain TNF drives post-inflammation depression-like behavior and persistent pain in experimental arthritisFernando Lopes, Fernando A Vicentini, Nina L Cluny, et al.
CMAJ Open|June 10, 2017
Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort studyKeith C K Lau, Abdel Aziz Shaheen, Alexander A Aspinall, et al.
Canadian Liver Journal|December 25, 2023
Real-world tertiary referral centre experience stopping nucleos(t)ide analogue therapy in patients with chronic hepatitis BHassan Azhari, Alexandra D Frolkis, Abdel Aziz Shaheen, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2020
Real-world clinical and virological outcomes in a retrospective multiethnic cohort study of 341 untreated and tenofovir disoproxil fumarate-treated chronic hepatitis B pregnant patients in North AmericaGolasa Samadi Kochaksaraei, Eliana Castillo, Matthew D Sadler, et al.
Journal of Hepatology|March 25, 2024
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort studyChristina G Plagiannakos, Gideon M Hirschfield, Ellina Lytvyak, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label StudyJordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Pageof 14